Skip to main content
Complify AIComplifyAI

Live today · Food supplements · Czech Republic

Food‑supplement compliance, with a legal source for every verdict.

Each substance and claim is checked against EU and national rules, using decision logic validated with Havel & Partners.

Request a demoPlatform login

Five fields, no account. A person from the team replies.

Illustrative

Northfield Nutrition s.r.o. (fictional)

Portfolio overview

Food supplements · Czech Republic · rule-set 2026.10.1

Products checked

142

Open findings

7

Your products

  • Vitality Complex MenYohimbe prohibitedProhibited
  • Ashwagandha CalmIn expert reviewNeeds further analysis
  • B-Complex ForteLabel warning requiredRestricted
Illustrative example — fictional products and values, drawn from the platform's own screens.

Inside every check

What the engine checks today

Live and beta capabilities

Planned

Planned capabilities

  • API
  • Further EU markets
  • Further product categories

Why teams use it

Three things a product review costs you today

With Complify AI

A legal source for every verdict

Each substance and claim gets a verdict: permitted, restricted, prohibited or needs further analysis, with its legal source, regulation version and effective date.

Time

Weeks before a launch can go ahead

A manual review of one product for one market takes days to weeks, and it is repeated for every new market and every reformulation.

Law-firm turnaround, 2 to 10 working days per product and market. [FOUNDER INPUT: source for 2 to 10 working days (#15)]

Cost

Hundreds of euros per product, per market

Law-firm and consultancy price lists start at about €200 per product and market in the Czech Republic, and run higher in Western Europe. [FOUNDER INPUT: confirm €200 figure and attribution (#15)]

Czech and Western-European price lists, 2024 to 2025.

Currency

A review that is only current on the day it is issued

EU law leaves room for national rules on substances, limits, labelling and notification, so 27 national rule sets sit on top of it and keep changing.

Directive 2002/46/EC, Art. 4(7) and 11(2); Regulation (EU) No 1169/2011, Art. 39.

Escalation

Items a lawyer should see go to a lawyer

Items that need a lawyer move to expert review in the same workflow.

How it works

One product, one market, one run of the engine.

  1. Step 1: Product data in

    You enter the product as it is: ingredients, forms, doses, claims and the label. Names in any language are mapped to the canonical substance and form.

  2. Step 2: Rules and expert modules run

    A rule layer applies explicit, versioned decision rules written with lawyers. Domain expert modules for chemistry, biology, toxicology and nutrition answer the scientific questions. Agentic workflows run them per substance, and a verification layer checks every statement against its source.

  3. Step 3: Audit-ready report out

    Each substance and claim gets a verdict: permitted, restricted, prohibited or needs further analysis. Every statement carries its legal source, regulation version and effective date. Items that need a lawyer are escalated in the same workflow.

    Needs further analysisexpert review by a specialist or the partner law firm

Rules decide; the language model only prepares and checks inputs.

Assurance

Three levels of assurance, one workflow

Choose how far a question should go.

Automated screening

Live today

Automated screening

The engine returns a verdict for every substance and claim, with the deciding rule and its source.

You receive

  • Report in PDF and Excel
  • Citation, version and effective date per statement
  • Items marked "needs further analysis"

Automated screening is a compliance-support tool, not legal advice.

Expert-reviewed assessment

Available on request

Expert-reviewed assessment

A regulatory specialist or a lawyer from our partner law firm reviews the flagged items and the report. [FOUNDER INPUT: who performs tier 2 (#6)]

You receive

  • Reviewed report
  • Reviewer notes on each flagged item
  • Updated verdicts

A review supports your decision; it is not a formal legal opinion.

Formal legal opinion

Coming soon

Formal legal opinion

Once launched, Havel & Partners will issue a formal legal opinion on the escalated question, with any conditions that apply. Until then, expert review covers escalated items.

You receive

  • Signed opinion as PDF
  • Conditions for placing the product on the market
  • Verdicts updated in the platform

Issued under the law firm's professional responsibility and billed by the law firm.

Illustrative

legal-opinion.pdf

Signed PDF · qualified electronic signature

Partner law firm

Conditions:Daily doseLabel warningsTarget group
Coming soon

How the tiers and escalation work

Audiences

Who it is for

For brands, contract manufacturers, retailers and their advisers.

  • Brands and manufacturers

    Screen the whole portfolio per market; take only open questions to a lawyer.

    Portfolio screening
    What gets in the way

    Every new product, market or reformulation restarts the review.

  • Contract manufacturers

    One structured assessment per product and market, exportable for each client.

    Export per client
    What gets in the way

    You carry many clients' formulations into many markets at once.

  • Retailers and marketplaces

    A documented, citable check before a product is listed.

    Check before listing
    What gets in the way

    Own-brand and third-party listings put the responsibility for the product on you.

  • Law firms and regulatory consultants

    Use the engine for screening and validation; your sign-off stays yours.

    Screening + validation
    What gets in the way

    Triage takes the hours that should go into judgement.

  • Regulators

    The same engine and audit trail can serve supervision. No authority is a customer today.

    Same audit trail
    What gets in the way

    Checking products on the market at portfolio scale needs the same rules and the same trail.

Partners

Built with a law firm, backed by an investor

Havel & Partners

Havel & Partners is Complify AI's partner law firm. [FOUNDER INPUT: add "and shareholder" once the SHA is executed and visible in the register (#20); approved firm description (#4)]

  • Its lawyers co-author and validate the decision logic the engine applies
  • Once that tier launches: formal legal opinions issued by the firm under its professional responsibility
  • A partner of the firm sits on the Complify AI strategy board
  • Coverage: Czech Republic and Slovakia

[FOUNDER INPUT: confirm wording for other markets, e.g. "Other markets are served through partner law firms." (#4)]

TCF Capital

TCF Capital is an investor in Complify AI and funded the development of the first product. An investment director of TCF Capital sits on the strategy board.

Decision record · yohimbe bark extractrule-set 2026.10.1
Listed: Reg. (EC) No 1925/2006, Annex III Part A
Plant part: bark · form: dry extract
Verdict: prohibited in all EU markets
Also prohibited in CZ: Decree No 58/2018 Coll., Annex 2 Part 1

Rule written and validated with the partner law firm

To our knowledge no tool combines lawyer-encoded national decision logic, domain-expert reasoning over substance identity and statement-level provenance with a formal legal opinion from a Tier-1 law firm in the same workflow.

Team and strategy board

Coverage

What is live today, and what is planned

Each market and product category is a separate module, so coverage grows one validated module at a time.

Live today

Live today

Product categories
Food supplements
Markets
Czech Republic (EU law plus the Czech national layer)
BetaContinuous monitoring
Registered products are re-checked against regulatory change, with the changed rule and affected products reported. In beta with design partners. [FOUNDER INPUT: confirm "beta" wording (#12)]
Planned

Planned

Product categories
Fortified foodInfant foodCosmetics
Markets
Further EU markets, each as a separately validated module, including France, Germany, Italy, Poland and Spain. Sequence shared on request.

No dates are published. [FOUNDER INPUT: add target years if they may be published (#14)]

Next step

See it on your own products

Five fields, no account; a person from the team replies to arrange a session on your portfolio and market.

Request a demoOr look at an example report first